The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
KEYNOTE-B49: A phase 3, randomized, double-blind, placebo-controlled study of pembrolizumab plus chemotherapy in patients with HR+/HER2- locally recurrent inoperable or metastatic breast cancer.
 
Hope S. Rugo
Honoraria - Mylan; Puma Biotechnology; Samsung Bioepis
Consulting or Advisory Role - Napo Pharmaceuticals
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst)
 
Joohyuk Sohn
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Other Relationship - Roche
 
Yolanda Jerez Gilarranz
Honoraria - Novartis; Roche
Consulting or Advisory Role - Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche
 
Lucia Gonzalez-Cortijo
Expert Testimony - GlaxoSmithKline
 
Amir Sonnenblick
Consulting or Advisory Role - Gilead Sciences; Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - Pfizer; Roche; Teva
Travel, Accommodations, Expenses - Celgene; NeoPharm
Other Relationship - Novartis
 
Dhanusha Sabanathan
No Relationships to Disclose
 
Ernesto Pablo Korbenfeld
Consulting or Advisory Role - MSD; Novartis; Pfizer; Roche
 
Daniel Egle
Honoraria - Amgen; AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
 
Brigitte Poirier
Consulting or Advisory Role - Novartis; Pfizer; Roche
 
Flora Zagouri
Honoraria - AstraZeneca; Daiichi Sankyo; Lilly; Merck; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Lilly; Merck; Novartis; Pfizer
 
Alexios Matikas
Honoraria - Veracyte
 
Sercan Aksoy
Honoraria - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck; Merck Sharp & Dohme; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck; Merck Sharp & Dohme; Novartis; Pfizer
 
Umut Demirci
Consulting or Advisory Role - Abdi Ibrahim; Bristol-Myers Squibb; MSD; Novartis; Roche; Teva
Travel, Accommodations, Expenses - Lilly; MSD; Roche
 
Pier Ramos-Elias
No Relationships to Disclose
 
Seock-Ah Im
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; GlaxoSmithKline; Hanmi; Lilly; MSD; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Daewoong Pharmaceutical (Inst); Eisai (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Other Relationship - Roche
 
Fatima Cardoso
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; GE Healthcare; Genentech; Gilead Sciences; GlaxoSmithKline; IQvia; Macrogenics; Medscape; Merck Sharp & Dohme; Merus; Mundipharma; Mylan; Novartis; Pfizer; Pierre Fabre; Prime Oncology; Roche; Samsung Bioepis; Sanofi; Seagen; Teva; touchIME
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer; Roche
 
Liyi Jia
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Carlos Baccan
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Konstantinos Tryfonidis
No Relationships to Disclose
 
Peter Schmid
Employment - Roche (I)
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Celgene; Eisai; Merck; Novartis; Pfizer; Puma Biotechnology; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Celgene; Eisai; Genentech/Roche (I); Merck; Novartis; Pfizer; Puma Biotechnology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Genentech (Inst); Medivation; Novartis (Inst); Oncogenex (Inst); Roche (Inst)